BioNxt Solutions Inc.
BNXTF
$0.3747
$0.0257.15%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.07M | -712.10K | -1.17M | -1.81M | -1.05M |
| Total Depreciation and Amortization | 16.90K | 16.70K | 17.20K | 31.60K | 36.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 331.90K | 230.10K | 180.70K | 330.00K | 246.80K |
| Change in Net Operating Assets | 557.10K | -69.10K | 236.80K | 497.00K | -39.90K |
| Cash from Operations | -169.00K | -534.50K | -732.60K | -952.80K | -803.80K |
| Capital Expenditure | -- | -- | -- | -62.00K | 0.00 |
| Sale of Property, Plant, and Equipment | 0.00 | 41.10K | -- | 222.20K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 41.10K | -- | 160.20K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -9.30K | -9.20K |
| Issuance of Common Stock | 0.00 | 945.00K | 768.00K | 943.30K | 1.46M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -43.20K | -61.40K | -93.90K | -116.60K |
| Cash from Financing | 0.00 | 659.00K | 524.10K | 617.50K | 992.80K |
| Foreign Exchange rate Adjustments | 700.00 | 200.00 | 100.00 | 1.80K | -1.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -168.30K | 165.90K | -208.50K | -173.40K | 187.90K |
